Transgenic animals and plants are organisms that have been genetically modified to carry genes from another species, enabling them to express desirable traits. Here’s an overview of their significance:
Transgenic Animals
Transgenic animals are genetically engineered to exhibit traits that benefit agriculture, medicine, and research.
Examples:
- GloFish – Fluorescent fish created for research and commercial purposes.
- Transgenic Cows – Engineered to produce milk with human proteins for medicinal use.
- GM Salmon – Grows faster than wild salmon, improving food production efficiency.
- Disease-Resistant Pigs – Modified to resist specific viral infections (e.g., PRRS-resistant pigs).
- Oncomouse – Genetically modified for cancer research.
Applications:
- Medical Research – Development of disease models for human disorders.
- Pharmaceutical Production – Animals engineered to produce therapeutic proteins (e.g., insulin, clotting factors).
- Agriculture – Enhanced growth rates and disease resistance in livestock.
- Organ Transplantation (Xenotransplantation) – Pigs modified for human organ transplantation.
Transgenic Plants
Transgenic plants are genetically altered to enhance productivity, nutritional value, or resistance to pests, diseases, and environmental stress.
Examples:
- Bt Crops (e.g., Bt Cotton, Bt Corn) – Contain Bacillus thuringiensis (Bt) genes for pest resistance.
- Golden Rice – Enriched with beta-carotene to address Vitamin A deficiency.
- Herbicide-Resistant Soybeans – Allow farmers to use herbicides without harming crops.
- Drought-Tolerant Maize – Designed to withstand water scarcity.
- Virus-Resistant Papaya – Engineered to resist the papaya ringspot virus.
Applications:
- Agricultural Productivity – Increased crop yields and resistance to pests/diseases.
- Nutritional Enhancement – Fortification of crops with essential vitamins and minerals.
- Environmental Benefits – Reduced pesticide use and lower carbon footprint.
- Biofuels – Development of genetically engineered plants for renewable energy sources.
Ethical and Regulatory Considerations
- Concerns: Potential risks include biodiversity loss, allergenicity, and ethical debates over genetic modification.
- Regulations: Governed by agencies such as the FDA, USDA, WHO, and EPA to ensure safety and sustainability.
Would you like a deeper dive into any specific aspect, such as a case study or white paper on transgenic organisms? 😊
What is required Transgenic Animals and Plants
Requirements for Transgenic Animals and Plants
Creating transgenic animals and plants involves multiple scientific, regulatory, ethical, and technological requirements. Below are the key aspects necessary for developing transgenic organisms:
1. Scientific and Technical Requirements
For Transgenic Animals:
- Gene Identification & Selection – Identification of desirable genes from other species (e.g., disease resistance, faster growth).
- Gene Insertion Methods – Techniques like microinjection, CRISPR-Cas9, retroviral vectors, or electroporation to introduce foreign DNA.
- Embryo Manipulation & Implantation – Insertion of modified embryos into surrogate mothers to produce transgenic offspring.
- Phenotypic & Genotypic Testing – Verification of successful gene expression and desired traits in the animal.
For Transgenic Plants:
- Gene Isolation & Modification – Selection and engineering of genes responsible for traits like pest resistance or enhanced nutrition.
- Transformation Methods:
- Agrobacterium tumefaciens-mediated gene transfer (natural plant transformation system).
- Gene gun (biolistic method) to introduce foreign DNA directly into plant cells.
- CRISPR-Cas9 for precise genome editing.
- Tissue Culture & Regeneration – Growing modified plant cells into full plants.
- Field Trials & Stability Testing – Ensuring stable inheritance of traits across generations.
2. Regulatory and Legal Requirements
- Approval from Regulatory Bodies:
- United States: USDA, FDA, EPA regulate transgenic crops and animals.
- Europe: European Food Safety Authority (EFSA) oversees GMOs.
- India: Genetic Engineering Appraisal Committee (GEAC) grants approvals.
- Global Organizations: WHO, Codex Alimentarius, and Cartagena Protocol regulate biosafety.
- Biosafety Assessments:
- Environmental impact studies (effects on biodiversity and ecosystems).
- Food safety tests (allergenic potential, toxicity).
- Labeling & Public Disclosure:
- Some countries require GMO labeling for consumer awareness.
- Patent & Intellectual Property Rights:
- GMOs often involve patents (e.g., Monsanto’s Roundup Ready crops).
3. Ethical & Societal Considerations
- Animal Welfare: Ensuring ethical treatment of genetically modified animals.
- Public Perception & Acceptance: Addressing concerns about GMO safety and ecological impact.
- Religious & Cultural Considerations: Some communities oppose GMOs due to ethical or religious beliefs.
4. Industrial and Commercial Requirements
- Infrastructure & Investment: Biotechnology labs, gene editing equipment, and skilled scientists.
- Supply Chain & Distribution: Availability of biotech seeds, regulatory-compliant farming methods.
- Market Access & Trade Policies: Compliance with international GMO trade laws.
Would you like more details on a specific area, such as a case study or a white paper on transgenic organisms? 😊
Courtesy : Peekaboo Kidz
Who is required Transgenic Animals and Plants
Who Requires Transgenic Animals and Plants?
Transgenic animals and plants are used by various industries, researchers, and regulatory bodies for different purposes. Here are the key stakeholders who require and benefit from them:
1. Agricultural Sector
- Farmers & Agribusinesses:
- Require transgenic crops (e.g., Bt cotton, herbicide-resistant soybeans) for higher yields and pest resistance.
- Use genetically modified livestock for disease resistance, faster growth, and improved meat/milk production.
- Food Companies & Producers:
- Utilize genetically modified plants (e.g., Golden Rice with vitamin A) to enhance nutritional value.
- Source genetically modified animal products (e.g., omega-3 enriched eggs, fast-growing salmon).
2. Pharmaceutical & Medical Research Organizations
- Biomedical Scientists & Genetic Engineers:
- Use transgenic animals (e.g., Oncomouse for cancer research) to study human diseases and drug testing.
- Develop biopharmaceuticals from genetically modified animals (e.g., goats producing human insulin in milk).
- Pharmaceutical Companies:
- Require transgenic plants as biofactories for vaccine and drug production (e.g., tobacco plants for COVID-19 vaccine research).
- Develop gene therapy treatments using genetically engineered organisms.
- Hospitals & Healthcare Providers:
- Benefit from medical advancements through transgenic animals for xenotransplantation (e.g., genetically modified pigs for organ transplants).
3. Environmental & Industrial Sectors
- Bioremediation Companies:
- Use genetically modified plants and bacteria to clean up oil spills, heavy metals, and environmental pollutants.
- Biofuel Industry:Requires genetically engineered crops (e.g., high-yield sugarcane, algae) for efficient biofuel production.
4. Government & Regulatory Bodies
- Food and Agriculture Organizations (FAO, USDA, EFSA, GEAC, WHO, etc.):Regulate the safety, environmental impact, and commercialization of GMOs.
- Intellectual Property & Patent Authorit Monitor patent rights on transgenic seeds and animal modifications (e.g., Monsanto, CRISPR technology).
- Ethics Committees & Animal Welfare Groups:
- Ensure ethical guidelines for genetic modification of animals.
5. Consumers & Society
- Consumers:
- Demand GMOs for better food security, improved nutrition, and affordable produce.
- Require transparency and labeling on GMO products.
- Academia & Universities: Conduct research on genetic engineering and its long-term effects.
Would you like more details on a specific stakeholder, such as a case study on a biotech company using transgenic organisms? 😊
when Are Transgenic Animals and Plants Required?
Transgenic animals and plants are required in various situations across agriculture, medicine, research, industry, and environmental conservation. Here are key scenarios where they are needed:
1. Agriculture and Food Security
📌 When there is a need for higher crop yields and food production
- To address food shortages in rapidly growing populations.
- During pest outbreaks (e.g., Bt crops resist pests like the cotton bollworm)
- In regions with drought or poor soil conditions, drought-resistant crops are essential.
📌 When livestock improvement is needed
- For disease resistance in farm animals (e.g., PRRS-resistant pigs).
- To improve meat, milk, or egg production efficiency (e.g., fast-growing salmon).
2. Medical and Pharmaceutical Applications
📌 When developing new drugs or vaccines
- For biopharmaceutical production, e.g., transgenic goats that produce human insulin in milk
- In times of pandemics, transgenic plants are used for rapid vaccine development (e.g., plant-based COVID-19 vaccines).
📌 When studying human diseases
- For genetic disorder research, transgenic mice are engineered to model human diseases (e.g., Alzheimer’s, cancer, diabetes).
📌 When organ transplantation demand is high
- For xenotransplantation, genetically modified pigs provide organs compatible with human transplant patients.
3. Environmental Protection & Sustainability
📌 When there is a need for bioremediation
- To clean up oil spills, heavy metal pollution, or toxic waste, genetically modified plants absorb pollutants from soil and water.
📌 When developing alternative energy sourc
For biofuel production, GM algae and high-yield crops are required for sustainable energy solutions.
4. Industrial and Commercial Uses
📌 When there is a demand for bio-based materials
- For biodegradable plastics and fibers, transgenic plants are used as raw material sources.
📌 When improving agricultural economics
- To reduce dependence on chemical pesticides and herbicides, transgenic plants with built-in resistance help lower costs.
5. Scientific Research & Technological Advancements
📌 When new genetic engineering techniques need to be tested
- CRISPR-Cas9 gene editing research often involves transgenic animals and plants to understand gene functions.
📌 When improving livestock breeding programsFor precision breeding, genetic modifications ensure desirable traits in future generations.
Conclusion
Transgenic animals and plants are required whenever there is a need to improve agriculture, medicine, environmental sustainability, or scientific progress. Their use becomes crucial in times of food shortages, disease outbreaks, environmental crises, and industrial innovation.
Would you like a case study on a specific application of transgenic organisms? 😊
Courtesy : Kurzgesagt – In a Nutshell
Where is required Transgenic Animals and Plants
Where Are Transgenic Animals and Plants Required?
Transgenic animals and plants are needed in various sectors and locations worldwide, depending on agricultural, medical, industrial, and environmental needs. Below are key areas where they are required:
1. Agriculture & Farming Regions 🌾🐄
📍 Where food production needs improvement
- Countries with food insecurity (e.g., Sub-Saharan Africa, parts of Asia) use drought-resistant crops.
- Large-scale farms in North & South America use pest-resistant Bt cotton and herbicide-tolerant soybeans.
📍 Where livestock breeding and dairy farming are key
- Countries like the U.S., China, and Brazil use genetically modified cows and pigs for higher meat and milk production.
- Aquaculture hubs (e.g., Canada, Norway) use fast-growing transgenic salmon for sustainable fish farming.
2. Pharmaceutical & Medical Research Centers 🏥🔬
📍 Where disease research and drug production occur
- Biotechnology hubs (e.g., U.S., Germany, UK, Japan) use transgenic mice for studying diseases like cancer and Alzheimer’s.
- Medical research labs in universities and pharma companies create genetically modified animals for drug testing.
📍 Where vaccines and medicines are produced
- Transgenic plants like tobacco are used for vaccine production (e.g., COVID-19 plant-based vaccines in Canada).
- Transgenic goats in the U.S. and Argentina produce medicines like insulin in their milk.
3. Environmental Conservation Areas 🌍♻️
📍 Where ecosystem restoration is needed
- Polluted regions (e.g., industrial zones in China, U.S.) use GM plants for bioremediation to absorb heavy metals.
- Forested areas affected by climate change use transgenic trees for carbon capture.
📍 Where biodiversity needs protection
- Coral reef restoration projects (e.g., Australia’s Great Barrier Reef) explore gene-modified corals resistant to warming.
4. Industrial & Commercial Production Sites 🏭🌱
📍 Where biofuels and sustainable materials are developed
- Brazil, U.S., and Europe use genetically modified crops (e.g., sugarcane, algae) for biofuel production.
- Clothing and packaging industries use GM cotton and biodegradable plastics from modified plants.
5. Scientific Research & Universities 🎓🔍
📍 Where genetic engineering research is conducted
- Top research universities and biotech firms (e.g., MIT, Stanford, Oxford, CRISPR labs) test new transgenic technologies.
- Agricultural research centers (e.g., IRRI in the Philippines, CIMMYT in Mexico) develop GM rice and wheat.
Conclusion
Transgenic animals and plants are required wherever there is a need for better food production, medical advancements, environmental solutions, or industrial innovations. Key locations include farming regions, research centers, pharmaceutical hubs, and conservation areas worldwide.
Would you like a specific case study on a country or industry using transgenic technology? 😊
How is required Transgenic Animals and Plants
How Are Transgenic Animals and Plants Required?
The requirement for transgenic animals and plants is determined by scientific, economic, medical, and environmental needs. The process involves multiple steps, from identifying the need to applying genetic modifications for practical use. Below is a breakdown of how transgenic organisms are required in different fields.
1. Identifying the Need for Transgenic Organisms
Before transgenic animals or plants are developed, scientists and industries determine the specific problems they aim to solve. These include:
✔ Food shortages → Drought-resistant crops
✔ Pest infestations → Insect-resistant plants (e.g., Bt crops)
✔ Disease research → Transgenic mice for Alzheimer’s studies
✔ Vaccine production → Genetically modified tobacco for COVID-19 vaccines
✔ Environmental pollution → GM plants for bioremediation
2. Research and Genetic Engineering Process
Once a need is identified, scientists use biotechnology to create transgenic organisms:
🔬 Gene Identification – The desired trait (e.g., disease resistance) is located in another species.
🧬 Gene Insertion – The trait is inserted into the target plant or animal using gene-editing techniques (e.g., CRISPR, Agrobacterium).
🌱 Testing & Trials – GM crops and animals undergo safety testing in labs and field trials.
📜 Regulatory Approval – Governments evaluate safety before commercialization (e.g., FDA, EFSA, WHO).
3. Implementation in Key Sectors
📌 Agriculture:
- Transgenic crops (e.g., Golden Rice with Vitamin A) are required for improving nutrition.
- Drought-resistant wheat is developed for dry regions.
📌 Medicine
Transgenic animals (e.g., genetically modified pigs for organ transplants) are used in medical research.
- Biopharmaceuticals (e.g., GM goats producing insulin in milk) are used for medicine production.
📌 Industry & Environment:
- GM algae are needed for biofuel production
- Transgenic trees help reduce carbon emissions.
4. Regulation and Ethical Considerations
Governments and organizations (WHO, FDA, EU) regulate how transgenic organisms are used. Ethical concerns are reviewed, especially for animal welfare and biodiversity protection.
Conclusion
Transgenic animals and plants are required through a step-by-step scientific, regulatory, and industrial process. Their development follows a structured path from problem identification to genetic modification, testing, approval, and practical use in agriculture, medicine, and environmental protection.
Would you like a case study on how a specific transgenic organism was developed? 😊
Courtesy: Biology ScienceSK
Case Study on Transgenic Animals and Plants
Case Study on Transgenic Animals and Plants
Case Study 1: Transgenic Animal – The GloFish (Genetically Modified Fluorescent Fish) 🐠
Background:
The GloFish was the first genetically modified animal to be commercially available as a pet. It was originally developed for environmental monitoring but became popular in the aquarium industry.
Genetic Modification:
Scientists inserted a fluorescent protein gene from jellyfish and sea anemones into zebra fish (Danio rerio), making them glow under UV light.
Applications:
✅ Originally designed to detect water pollution by glowing in response to toxins.
✅ Later commercialized as a pet in various colors (red, green, blue, purple).
✅ Used in biomedical research to study genetic diseases and cell development.
Regulation & Ethical Concerns:
- The U.S. FDA (Food and Drug Administration) ruled that GloFish posed no environmental risks
- Some countries (e.g., Canada) banned their sale due to ecological concerns.
Case Study 2: Transgenic Plant – Golden Rice 🌾
Background:
Vitamin A deficiency affects millions, causing blindness and immune deficiencies. Scientists developed Golden Rice, a genetically modified crop that produces beta-carotene (provitamin A).
Genetic Modification:
The phytoene synthase gene (psy) from daffodils and the crtI gene from soil bacteria were inserted into rice DNA to produce beta-carotene in the grains.
Applications & Benefits:
✅ Addresses malnutrition, especially in developing countries like India, Bangladesh, and the Philippines.
✅ One bowl of Golden Rice can provide 50% of daily Vitamin A needs.
✅ Helps reduce child mortality related to Vitamin A deficiency.
Challenges & Regulation:
- Approved in the Philippines for cultivation in 2021.
- Opposition from anti-GMO groups slowed adoption in some countries.
- Ongoing studies to improve yield and beta-carotene retention.
Conclusion
Both GloFish and Golden Rice show how transgenic organisms solve real-world problems—whether in science, environment, or health. While Golden Rice fights malnutrition, GloFish serves in research and commercial markets. However, regulatory, ethical, and environmental factors play crucial roles in their global acceptance.
Would you like a case study on a specific industry (medicine, agriculture, etc.)? 😊
White Paper on Transgenic Animals and Plants
The white paper on Transgenic Animals and Plants has been drafted. Let me know if you need any modifications or additional sections! 😊
Industrial Application on Transgenic Animals and Plants
White Paper on Transgenic Animals and Plants
1. Introduction Transgenic animals and plants are organisms that have been genetically modified through the insertion of foreign genes to enhance desirable traits. This biotechnology has revolutionized agriculture, medicine, and industry by offering solutions to food security, disease resistance, and biopharmaceutical production. However, the ethical, environmental, and regulatory challenges surrounding transgenic organisms require careful evaluation.
2. Scientific Basis of Transgenics Transgenesis involves the introduction of specific genes from one species into another using genetic engineering techniques such as:
- Recombinant DNA technology
- CRISPR-Cas9 gene editing
- Agrobacterium-mediated transformation (for plants)
- Microinjection and viral vectors (for animals)
These techniques enable the precise modification of an organism’s genome to achieve targeted traits.
3. Applications of Transgenic Plants
Agriculture: Crops like Bt cotton and Bt maize are engineered for pest resistance, reducing pesticide use and increasing yield.
- Nutritional Enhancement: Golden Rice is fortified with Vitamin A to combat malnutrition.
- Environmental Benefits: Transgenic poplar trees are used in bioremediation to absorb heavy metals from contaminated soil
- Industrial Uses: Genetically modified algae and soybeans produce biofuels and biodegradable plastics.
4. Applications of Transgenic Animals
- Biomedical Research: Transgenic mice are widely used for studying human diseases like cancer and Alzheimer’s.
- Pharmaceuticals: Transgenic goats and cows produce therapeutic proteins like insulin and clotting factors in their milk
- Agriculture: Genetically modified salmon (AquaBounty) grow faster, increasing fish farming efficiency.
- Xenotransplantation: Pigs engineered to have human-compatible organs are being developed to address organ transplant shortages.
5. Industrial Applications of Transgenic Animals and Plants
- Biopharmaceutical Production: Transgenic animals are used to produce human monoclonal antibodies, hormones (e.g., insulin), and clotting factors for medical treatments
- Biofactories: Transgenic plants like tobacco are engineered to produce vaccines and industrial enzymes, reducing production costs. Textile Industry: Genetically modified silkworms produce stronger and more durable silk for industrial use.
- Food and Dairy Industry: Transgenic cows produce milk with enhanced nutritional profiles, including increased casein for better cheese production
- Bioremediation: Transgenic plants help remove heavy metals, pesticides, and toxic substances from industrial waste sites.
- Renewable Energy: Transgenic algae are being developed to produce biofuels as a sustainable alternative to fossil fuels.
6. Ethical and Environmental Concerns
- Biodiversity Risks: The potential for crossbreeding with wild species raises ecological concern
- Animal Welfare: Genetic modifications may cause unintended health issues in transgenic animals
- Food Safety: Regulatory bodies like the FDA, EFSA, and WHO assess risks before approving transgenic food products.
- Public Perception: Misinformation and ethical debates affect the acceptance of genetically modified organisms (GMOs) globally.
7. Regulatory Framework and Global Policies
- United States: The FDA, USDA, and EPA oversee GMOs for safety and environmental impact
- European Union: Stringent labeling laws and risk assessments govern the use of transgenic organisms.
- Developing Countries: Nations like India, China, and Brazil are rapidly adopting GMOs but face policy and public acceptance challenges.
8. Future Prospects and Innovations
- Gene-Editing Advances: CRISPR technology is making genetic modifications more precise and cost-effective.
- Synthetic Biology: New approaches to create entirely synthetic transgenic organisms.
- Climate-Resilient Crops: Development of drought- and salt-resistant transgenic plants.
- Bioengineered Disease Resistance: Animals engineered to resist zoonotic diseases could prevent future pandemics.
9. Conclusion Transgenic animals and plants hold immense potential for addressing global challenges in food security, healthcare, and environmental sustainability. However, scientific advancements must be balanced with ethical responsibility, regulatory oversight, and public engagement to ensure safe and effective implementation. Continued research, policy refinement, and transparent communication will be crucial for the future of transgenic biotechnology.
- “GloFish web page”. Archived from the original on 2021-01-20. Retrieved 2003-11-29.
- ^ “Glowy coriees=14 November 2022”. reef2rainforest. 6 September 2022. Archived from the original on 14 November 2022. Retrieved 14 November 2022.
- ^ “NUS – National University of Singapore”. nus.edu.sg. Archived from the original on 2021-01-25. Retrieved 2012-10-06.
- ^ Published PCT Application WO2000049150 “Chimeric Gene Constructs for Generation of Fluorescent Transgenic Ornamental Fish.” National University of Singapore [1] Archived 2021-05-06 at the Wayback Machine
- ^ “FDA Statement Regarding Glofish”. Food and Drug Administration. Archived from the original on 2010-03-05.
- ^ Charles Choi (January 7, 2004). “GloFish draw suit”. The Scientist. Archived from the original on July 1, 2015. Retrieved May 11, 2013.
- ^ Pet, Spectrum Brands. “Spectrum Brands Pet LLC Introduces GloFish® Sharks to GloFish® Family of Fluorescent Fish”. www.prnewswire.com (Press release). Archived from the original on 2020-02-12. Retrieved 2020-02-12.
- ^ “Finformation” (PDF). Greater Pittsburgh Aquarium Society. pp. 4–5. Archived from the original (PDF) on 2008-12-17.
- ^ “License Notice”. Archived from the original on 13 June 2021. Retrieved 13 June 2021.
- ^ “Letter from Director Charlton H. Bonham to Gene Livingston, Greenburg Traurig, LLC, regarding GloFish” (PDF). Archived from the original (PDF) on December 21, 2016. Retrieved February 17, 2017.
- ^ vrom.nl Archived March 9, 2007, at the Wayback Machine
- ^ “Genetically Engineered Animals”. fda.gov. Archived from the original on 2009-05-11. Retrieved 2019-12-16.
- ^ “Regulation of Genetically Engineered Animals Containing Heritable Recombinant DNA Constructs” (PDF). Food and Drug Administration. Archived (PDF) from the original on 2019-01-08. Retrieved 2019-12-16.
- ^ Hill, Jeffrey E.; Lawson, Larry L.; Hardin, Scott (2014). “Assessment of the Risks of Transgenic Fluorescent Ornamental Fishes to the United States Using the Fish Invasiveness Screening Kit (FISK)”. Transactions of the American Fisheries Society. 143 (3): 817–829. Bibcode:2014TrAFS.143..817H. doi:10.1080/00028487.2014.880741. Archived from the original on 2019-02-03. Retrieved 2014-07-04.
- ^ “Risk Assessment of Transgenic Fluorescent Ornamental Fishes to the United States Using FISK v2” (PDF). Archived from the original (PDF) on 2014-07-14. Retrieved 2014-07-04.
- ^ Peddie, Brian. “A Grounded Theory of Florida Aquarium Retailers’ Acceptance of the GloFish” (PDF). University of Florida. Archived (PDF) from the original on 2012-07-03. Retrieved 2013-06-25.
- ^ Hill, Jeffrey E.; Kapuscinski, Anne R.; Pavlowich, Tyler (2011). “Fluorescent Transgenic Zebra Danio More Vulnerable to Predators than Wild-Type Fish”. Transactions of the American Fisheries Society. 140 (4): 1001–1005. Bibcode:2011TrAFS.140.1001H. doi:10.1080/00028487.2011.603980.
- ^ Jump up to:abc
- Kalueff, Allan V. (2017). Kalueff, Allan V (ed.). The rights and wrongs of zebrafish: Behavioral phenotyping of zebrafish. Cham, Switzerland. pp. viii+327. doi:10.1007/978-3-319-33774-6. ISBN 978-3-319-33774-6. OCLC 971612231. S2CID 89757479. ISBN 978-3-319-81598-5. ISBN 978-3-319-33773-9.: 110, 115, 116
- Dougherty, Liam R. (2020-02-05). “Designing mate choice experiments”. Biological Reviews of the Cambridge Philosophical Society. 95 (3). Wiley Publishing (Cambridge Philosophical Society): 759–781. doi:10.1111/brv.12586. ISSN 1464-7931. PMID 32022418. S2CID 211035691.
- Delcourt, Johann; Ovidio, Michaël; Denoël, Mathieu; Muller, Marc; Pendeville, Hélène; Deneubourg, Jean-Louis; Poncin, Pascal (2018-09-06). “Individual identification and marking techniques for zebrafish”. Reviews in Fish Biology and Fisheries. 28 (4). Springer Science and Business Media: 839–864. Bibcode:2018RFBF…28..839D. doi:10.1007/s11160-018-9537-y. hdl:2268/227671. ISSN 0960-3166. S2CID 52269510.
- Tsang, Benjamin; Zahid, Hifsa; Ansari, Rida; Lee, Richard Chi-Yeung; Partap, Aman; Gerlai, Robert (2017). “Breeding Zebrafish: A Review of Different Methods and a Discussion on Standardization”. Zebrafish. 14 (6). Mary Ann Liebert: 561–573. doi:10.1089/zeb.2017.1477. ISSN 1545-8547. PMID 28873037. S2CID 12470678.
- Howard, Richard D.; Rohrer, Karl; Liu, Yiyang; Muir, William M. (2015). “Mate Competition and Evolutionary Outcomes in Genetically Modified Zebrafish (Danio Rerio)”. Evolution. 69 (5): 1101–1360. doi:10.1111/evo.12662. PMID 25873489. S2CID 24263468.
- Owen, M. Aaron; Rohrer, Karl; Howard, Richard D. (2012). “Mate choice for a novel male phenotype in zebrafish, Danio rerio“. Animal Behaviour. 83 (3). Elsevier (Association for the Study of Animal Behaviour & Animal Behavior Society): 811–820. CiteSeerX 10.1.1.710.3757. doi:10.1016/j.anbehav.2011.12.029. ISSN 0003-3472. S2CID 33290016.
- Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, vanTuinen P, Ledbetter DH, Barker DF, Nakamura Y, White R, Vogelstein B (April 1989). “Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas”. Science. 244 (4901): 217–21. Bibcode:1989Sci…244..217B. doi:10.1126/science.2649981. PMID 2649981.
- ^ Lee AS, Seo YC, Chang A, Tohari S, Eu KW, Seow-Choen F, McGee JO (September 2000). “Detailed deletion mapping at chromosome 11q23 in colorectal carcinoma”. Br. J. Cancer. 83 (6): 750–5. doi:10.1054/bjoc.2000.1366. PMC 2363538. PMID 10952779.
- ^ Bell R, Herring SM, Gokul N, Monita M, Grove ML, Boerwinkle E, Doris PA (June 2011). “High-resolution identity by descent mapping uncovers the genetic basis for blood pressure differences between spontaneously hypertensive rat lines”. Circ Cardiovasc Genet. 4 (3): 223–31. doi:10.1161/CIRCGENETICS.110.958934. PMC 3116070. PMID 21406686.
- ^ Sherman EA, Strauss KA, Tortorelli S, Bennett MJ, Knerr I, Morton DH, Puffenberger EG (November 2008). “Genetic mapping of glutaric aciduria, type 3, to chromosome 7 and identification of mutations in c7orf10”. Am. J. Hum. Genet. 83 (5): 604–9. doi:10.1016/j.ajhg.2008.09.018. PMC 2668038. PMID 18926513.
- ^ Jump up to:a b Broman KW, Weber JL (December 1999). “Long homozygous chromosomal segments in reference families from the centre d’Etude du polymorphisme humain”. Am. J. Hum. Genet. 65 (6): 1493–500. doi:10.1086/302661. PMC 1288359. PMID 10577902.
- ^ Zeliha Görmez; Burcu Bakir-Gungor; Mahmut Şamil Sağıroğlu (Feb 2014). “HomSI: a homozygous stretch identifier from next-generation sequencing data”. Bioinformatics. 30 (3): 445–447. doi:10.1093/bioinformatics/btt686. PMID 24307702.
- ^ Luo J, Emanuele MJ, Li D, Creighton CJ, Schlabach MR, Westbrook TF, Wong KK, Elledge SJ (May 2009). “A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene”. Cell. 137 (5): 835–48. doi:10.1016/j.cell.2009.05.006. PMC 2768667. PMID 19490893.
- ^ Jump up to:a b Fortier S, Bilodeau M, Macrae T, Laverdure JP, Azcoitia V, Girard S, Chagraoui J, Ringuette N, Hébert J, Krosl J, Mayotte N, Sauvageau G (2010). “Genome-wide interrogation of Mammalian stem cell fate determinants by nested chromosome deletions”. PLOS Genet. 6 (12): e1001241. doi:10.1371/journal.pgen.1001241. PMC 3000362. PMID 21170304.
- ^ Chen WJ, Lin Y, Xiong ZQ, Wei W, Ni W, Tan GH, Guo SL, He J, Chen YF, Zhang QJ, Li HF, Lin Y, Murong SX, Xu J, Wang N, Wu ZY (December 2011). “Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia”. Nat. Genet. 43 (12): 1252–5. doi:10.1038/ng.1008. PMID 22101681. S2CID 16129198.
- ^ Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, Ueda H, Cordell HJ, Eaves IA, Dudbridge F, Twells RC, Payne F, Hughes W, Nutland S, Stevens H, Carr P, Tuomilehto-Wolf E, Tuomilehto J, Gough SC, Clayton DG, Todd JA (2001). “Haplotype tagging for the identification of common disease genes”. Nat Genet. 29 (2): 233–7. doi:10.1038/ng1001-233. PMID 11586306. S2CID 3388593.